Beth A. Davison

12.2k total citations · 3 hit papers
156 papers, 6.6k citations indexed

About

Beth A. Davison is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Beth A. Davison has authored 156 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Cardiology and Cardiovascular Medicine, 31 papers in Pulmonary and Respiratory Medicine and 25 papers in Epidemiology. Recurrent topics in Beth A. Davison's work include Heart Failure Treatment and Management (113 papers), Cardiovascular Function and Risk Factors (38 papers) and Potassium and Related Disorders (23 papers). Beth A. Davison is often cited by papers focused on Heart Failure Treatment and Management (113 papers), Cardiovascular Function and Risk Factors (38 papers) and Potassium and Related Disorders (23 papers). Beth A. Davison collaborates with scholars based in United States, Italy and Netherlands. Beth A. Davison's co-authors include Gad Cotter, Marco Metra, Piotr Ponikowski, Adriaan A. Voors, John R. Teerlink, Christopher Edwards, John G.F. Cleland, Howard C. Dittrich, Christopher M. O’Connor and Michael M. Givertz and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Beth A. Davison

148 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

2022 439 citations Alexandre Mebazaa, Beth A. Davison et al. profile →
The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans From 9 Countries

2012 352 citations Albertino Damasceno, Bongani M. Mayosi et al. profile →
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

2020 263 citations Beth A. Davison, Gad Cotter et al. profile →

Peers

Countries citing papers authored by Beth A. Davison

Since Specialization

Citations

This map shows the geographic impact of Beth A. Davison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth A. Davison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth A. Davison more than expected).

Fields of papers citing papers by Beth A. Davison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth A. Davison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth A. Davison. The network helps show where Beth A. Davison may publish in the future.

Co-authorship network of co-authors of Beth A. Davison

This figure shows the co-authorship network connecting the top 25 collaborators of Beth A. Davison. A scholar is included among the top collaborators of Beth A. Davison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth A. Davison. Beth A. Davison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Generating Important Insights into the Spectrum and Outcomes of Acute Heart Failure Across the African Continent: The Sub-Saharan Africa Survey of Heart Failure (THESUS-HF II) 2025 ·Global Heart ·Karen Sliwa, Simon Stewart, Charle Viljoen, (unknown), (unknown), Albertino Damasceno, (unknown), Mahmoud U. Sani, George Nel, (unknown), Beth A. Davison, Gad Cotter	0
2	Cardiovascular Precision Medicine and Remote Intervention Trial Rationale and Design 2024 ·Journal of Clinical Medicine ·(unknown), Rachel A. Annunziato, (unknown), Gad Cotter, Beth A. Davison, Koji Takagi, (unknown), David Rubinstein, Eyal Shemesh	1
3	Enhanced Decongestive Therapy in Patients With Acute Heart Failure 2024 ·Journal of the American College of Cardiology ·Gad Cotter, Beth A. Davison, Ovidiu Chioncel	9
4	Impact of Mitral Regurgitation in Patients with Acute Heart Failure: Insights from the RELAX-AHF-2 Trial 2023 ·European Journal of Heart Failure ·Matteo Pagnesi, Marianna Adamo, Jozine M. ter Maaten, Iris E. Beldhuis, Gad Cotter, Beth A. Davison, G. Michael Felker, Gerasimos Filippatos, Barry Greenberg, Peter S. Pang, Piotr Ponikowski, Iziah E Sama, Thomas Severin, Claudio Gimpelewicz, Adriaan A. Voors, John R. Teerlink, Marco Metra	9
5	Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure 2023 ·Clinical Research in Cardiology ·Iris E. Beldhuis, Jozine M. ter Maaten, Sylwia M. Figarska, Kevin Damman, Peter S. Pang, Barry Greenberg, Beth A. Davison, Gad Cotter, Thomas Severin, Claudio Gimpelewicz, G. Michael Felker, Gerasimos Filippatos, John R. Teerlink, Marco Metra, Adriaan A. Voors	3
6	Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial 2023 ·Stem Cells Translational Medicine ·Satsuki Yamada, Jozef Bartúnek, Thomas J. Povsic, Gad Cotter, Beth A. Davison, Christopher Edwards, Atta Behfar, Marco Metra, Gerasimos Filippatos, Marc Vanderheyden, William Wijns, André Terzic	4
7	Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation 2021 ·European Journal of Internal Medicine ·Josep Tost, Pere Llorens, Gad Cotter, Beth A. Davison, Javier Jacob, Víctor Gil, Pablo Herrero, Francisco Javier Martín‐Sánchez, (unknown), Beatriz L. Rodríguez, (unknown), Juan Antonio Andueza, Ana Belén Mecina, Raquel Torres Gárate, Pascual Piñera, Aitor Alquézar‐Arbé, Begoña Espinosa, Alexandre Mebazaa, Ovidiu Chioncel, Óscar Miró	1
8	Worsening renal function in acute heart failure in the context of diuretic response 2021 ·European Journal of Heart Failure ·Johanna E. Emmens, Jozine M. ter Maaten, Yuya Matsue, Sylwia M. Figarska, Iziah E Sama, Gad Cotter, John G.F. Cleland, Beth A. Davison, G. Michael Felker, Michael M. Givertz, Barry Greenberg, Peter S. Pang, Thomas Severin, Claudio Gimpelewicz, Marco Metra, Adriaan A. Voors, John R. Teerlink	41
9	What can heart failure trialists learn from oncology trialists? 2021 ·European Heart Journal ·Faı̈ez Zannad, Gad Cotter, Ángeles García, Suzanne George, Beth A. Davison, Gemma A. Figtree, Kushal Prasad, Frank W. Rockhold, Richard L. Schilsky, Norman Stockbridge, Bertram Pitt, Javed Butler	8
10	N-Terminal pro BNP and Galectin-3 are Prognostic Biomarkers of Acute Heart Failure in Sub-Saharan Africa: Lessons from the BAHEF Trial 2020 ·ESC Heart Failure ·Mahmoud U. Sani, Albertino Damasceno, Beth A. Davison, Gad Cotter, Bongani M. Mayosi, Christopher Edwards, Fériel Azibani, (unknown), (unknown), (unknown), Karen Sliwa	8
11	Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure 2016 ·Circulation Heart Failure ·Jozine M. ter Maaten, Kevin Damman, Jennifer S. Hanberg, Michael M. Givertz, Marco Metra, Christopher M. O’Connor, John R. Teerlink, Piotr Ponikowski, Gad Cotter, Beth A. Davison, John G.F. Cleland, Daniel M. Bloomfield, Hans L. Hillege, Dirk J. van Veldhuisen, Adriaan A. Voors, Jeffrey M. Testani	111
12	Symptoms and Signs of Heart Failure at Admission and Discharge and Outcomes in the Sub-Saharan Acute Heart Failure (THESUS-HF) Registry 2016 ·Journal of Cardiac Failure ·Mahmoud U. Sani, Gad Cotter, Beth A. Davison, Bongani M. Mayosi, Albertino Damasceno, Christopher Edwards, Okechukwu S. Ogah, Charles Mondo, Anastase Dzudié, Dike Ojji, Charles Kouam Kouam, Ahmed Suliman, Gerald Yonga, (unknown), Fikru Maru, Bekele Alemayehu, Karen Sliwa	17
13	Growth Differentiation Factor 15 (GDF-15) in Patients Admitted for Acute Heart Failure: Results from the RELAX-AHF Study 2015 ·European Journal of Heart Failure ·Gad Cotter, Adriaan A. Voors, Margaret F. Prescott, G. Michael Felker, Gerasimos Filippatos, Barry Greenberg, Peter S. Pang, Piotr Ponikowski, Olga Milo, Tsushung A. Hua, Min Qian, Thomas M. Severin, John R. Teerlink, Marco Metra, Beth A. Davison	88
14	Early vs. Late Worsening Heart Failure During Acute Heart Failure Hospitalization: Insights from the PROTECT Trial 2015 ·European Journal of Heart Failure ·Robert J. Mentz, Marco Metra, Gad Cotter, Olga Milo, (unknown), Karen Chiswell, Beth A. Davison, John G.F. Cleland, Daniel M. Bloomfield, Howard C. Dittrich, Mona Fiuzat, Piotr Ponikowski, Michael M. Givertz, Adriaan A. Voors, John R. Teerlink, Christopher M. O’Connor	20
15	Worsening Heart Failure, a Critical Event During Hospital Admission for Acute Heart Failure: Results from the VERITAS Study 2014 ·European Journal of Heart Failure ·Gad Cotter, Marco Metra, Beth A. Davison, Stefanie Senger, Robert C. Bourge, John G.F. Cleland, Guillaume Jondeau, Henry Krum, Christopher M. O’Connor, John D. Parker, Guillermo Torre‐Amione, Dirk J. van Veldhuisen, Olga Milo, Isaac Kobrin, Maurizio Rainisio, John J.V. McMurray, John R. Teerlink, (unknown)	23
16	Acute Heart Failure in Elderly Patients: Worse Outcomes and Differential Utility of Standard Prognostic Variables. Insights from the PROTECT Trial 2014 ·European Journal of Heart Failure ·Marco Metra, Robert J. Mentz, Karen Chiswell, Daniel M. Bloomfield, John G.F. Cleland, Gad Cotter, Beth A. Davison, Howard C. Dittrich, Mona Fiuzat, Michael M. Givertz, Valentina Lazzarini, George A. Mansoor, Barry M. Massie, Piotr Ponikowski, John R. Teerlink, Adriaan A. Voors, Christopher M. O’Connor	36
17	Renal Dysfunction in African Patients With Acute Heart Failure 2014 ·European Journal of Heart Failure ·Mahmoud U. Sani, Beth A. Davison, Gad Cotter, Karen Sliwa, Christopher Edwards, (unknown), Albertino Damasceno, Bongani M. Mayosi, Okechukwu S. Ogah, Charles Mondo, Anastase Dzudié, Dike Ojji, A.A. Voors	10
18	Sex-Specific Acute Heart Failure Phenotypes and Outcomes from PROTECT 2013 ·European Journal of Heart Failure ·Sven Meyer, Peter van der Meer, Barry M. Massie, Christopher M. O’Connor, Marco Metra, Piotr Ponikowski, John R. Teerlink, Gad Cotter, Beth A. Davison, John G.F. Cleland, Michael M. Givertz, Daniel M. Bloomfield, Mona Fiuzat, Howard C. Dittrich, Hans L. Hillege, Adriaan A. Voors	48
19	The PROTECT In-Hospital Risk Model: 7-Day Outcome in Patients Hospitalized with Acute Heart Failure and Renal Dysfunction 2012 ·European Journal of Heart Failure ·Christopher M. O’Connor, Robert J. Mentz, Gad Cotter, Marco Metra, John G.F. Cleland, Beth A. Davison, Michael M. Givertz, George A. Mansoor, Piotr Ponikowski, John R. Teerlink, Adriaan A. Voors, Mona Fiuzat, Daniel Wojdyla, Karen Chiswell, Barry M. Massie	102
20	Early Drop in Systolic Blood Pressure and Worsening Renal Function in Acute Heart Failure: Renal Results of Pre-RELAX-AHF 2011 ·European Journal of Heart Failure ·Adriaan A. Voors, Beth A. Davison, G. Michael Felker, Piotr Ponikowski, Elaine Unemori, Gad Cotter, John R. Teerlink, Barry Greenberg, Gerasimos Filippatos, Sam L. Teichman, Marco Metra	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact